WTR 26.59 Aqua America $WTR Hit a 52 week high of 26.71

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
WTR 26.59 Aqua America $WTR Hit a 52 week high of 26.71 Currently at 26.59 -0.07 -0.26% With a day low of 26.52 and a total volume of 61,940.

WTR Aqua America Recent Headline News

Connecticut Water Service Lags Q3 Earnings Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:20AM CST
Connecticut Water Service's third-quarter earnings fell short of the Zacks Consensus Estimate.
WTR: 26.51 (-0.15), AWK: 52.69 (+0.33), CWT: 25.43 (-0.48), CTWS: 36.22 (-0.68)

Water Related Stocks: Your Go to Guide to Getting Started in Water Investing
Reuben Brewer, The Motley Fool - Motley Fool - Sat Nov 08, 9:12AM CST
Roughly 97% of the water on this planet can't be used as drinking water. Of the 3% that can, about half is locked in polar ice. That leaves a paltry 1% or so of the world's water for more than 7 billion people (and counting) to share. That's why...
VE: 17.58 (-0.14), WTR: 26.51 (-0.15), CWCO: 12.22 (-0.28), AWK: 52.69 (+0.33), AEGN: 19.33 (+0.05)

Stock Screen: Best- And Worst-Performing Industries - Water Utilities
Value Line - at Seeking Alpha - Thu Nov 06, 9:57AM CST
By Robert M. Greene, CFA Among the many features found in each week's edition of Value Line's Selection & Opinion is a list of the seven best and worst performing industries over the past six weeks. These rankings can be found on the inside...
WTR: 26.51 (-0.15), AWK: 52.69 (+0.33), XLU: 46.31 (+0.06)

Upgrade Alert for Aqua America (WTR)
Comtex SmarTrend(R) - Wed Nov 05, 7:02AM CST
Aqua America (NYSE:WTR) was upgraded from Neutral to Buy at Hilliard Lyons today. The stock closed yesterday at $26.44 on volume of 683,000 shares, below average daily volume of 696,000. Over the past year, Aqua America has traded in a range of $22.40 to $26.50 and closed yesterday at $26.44, 18% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.4%.
WTR: 26.51 (-0.15)

Aqua America announces higher earnings of USD68m for Q3 2014
M2 - Wed Nov 05, 4:55AM CST
Water utility Aqua America (NYSE:WTR) disclosed on Tuesday its net income of USD68m the quarter ending 30 September 2014.
WTR: 26.51 (-0.15)

Aqua America's (WTR) CEO Nicholas DeBenedictis on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 11:20AM CST

WTR: 26.51 (-0.15)

Aqua America meets 3Q profit forecasts
Automated Insights - Tue Nov 04, 4:03AM CST
BRYN MAWR, Pa. (AP) _ Aqua America Inc. (WTR) on Tuesday reported third-quarter profit of $68 million.
WTR: 26.51 (-0.15)

Aqua America beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 5:30PM CST

WTR: 26.51 (-0.15)

Aqua America Reports Earnings Growth for the Third Quarter of 2014
Business Wire - Mon Nov 03, 5:28PM CST
Aqua America, Inc. (NYSE: WTR) today reported results for the quarter ending September 30, 2014. Income from continuing operations increased to $67.7 million from $62.7 million, or $0.38 per share from $0.35 per share from last year, an increase of 9 percent. Net income grew to $68 million from $63.6 million in the same quarter of 2013.
WTR: 26.51 (-0.15)

Insider Trading Alert - WTR, PTEN And SNX Traded By Insiders
at The Street - Mon Nov 03, 9:30AM CST
Stocks with insider trader activity include WTR, PTEN and SNX
WTR: 26.51 (-0.15), PTEN: 21.82 (-0.54), SNX: 70.15 (-0.88)

This Simple Strategy Can Supercharge Your Dividend Portfolio
Adam Galas, The Motley Fool - Motley Fool - Sat Nov 01, 7:00AM CDT
Source: Pixabay. There is a secret to investing success that some investors don't know: the power of dividend growth investing. It is one of the most powerful long-term wealth-building tools available to help achieve your financial dreams. For...
MMM: 157.17 (+0.62), JNJ: 108.61 (+0.41), WTR: 26.51 (-0.15), PNY: 37.73 (unch), HR: 26.25 (-0.07), PG: 89.14 (+0.01), AFL: 58.92 (+0.03)

Aqua Pennsylvania Reminds Low-Income Families There is Help to Pay Water Bills
Business Wire - Mon Oct 20, 1:19PM CDT
Aqua Pennsylvania (Aqua) is reminding customers that its Helping Hand assistance program is available to low-income families who find it difficult to pay their water bills.
WTR: 26.51 (-0.15)

Water Stocks: Great Promise But At What Cost?
Roger S. Conrad - at Seeking Alpha - Sun Oct 19, 10:55AM CDT

AWR: 34.88 (-0.20), PCG: 50.49 (+0.14), AWK: 52.69 (+0.33), CTWS: 36.22 (-0.68), AEGN: 19.33 (+0.05), VE: 17.58 (-0.14), WTR: 26.51 (-0.15), CG: 28.98 (+0.04), MSEX: 22.89 (+0.10), CWCO: 12.22 (-0.28), SJW: 30.78 (-0.63), CWT: 25.43 (-0.48), YORW: 21.92 (+0.06)

Aqua America to Report Earnings for the Third Quarter 2014
Business Wire - Thu Oct 16, 3:42PM CDT
Aqua America, Inc. (NYSE: WTR) expects to report earnings for the quarter ending September 30, 2014 on November 4, 2014.
WTR: 26.51 (-0.15)

Aqua America's subsidiary buys Water and Wastewater Systems in Burlington County
M2 - Fri Oct 10, 5:24AM CDT
Water utility Aqua America (NYSE:WTR) disclosed on Thursday the completion of the acquisition of the assets of the Spartan Village water and wastewater systems from Spartan Village for a purchase price of USD1.
WTR: 26.51 (-0.15)

Aqua America New Jersey Subsidiary Acquires Water and Wastewater Systems in Burlington County
Business Wire - Thu Oct 09, 12:32PM CDT
Aqua America, Inc. (NYSE: WTR) announced today that its New Jersey subsidiary, Aqua New Jersey, acquired the assets of the Spartan Village water and wastewater systems from Spartan Village, Inc. for $1, with plans to invest approximately $375,000 for upgrades to distribution pipes, meters and the wastewater plant. The systems serve approximately 650 people in North Hanover Township and Wrightstown Borough, both in Burlington County where Aqua New Jersey currently serves three other communities.
WTR: 26.51 (-0.15)

Aqua America's board reports 8.6% rise in quarterly dividend
M2 - Mon Oct 06, 5:24AM CDT
The board of directors of Aqua America (NYSE:WTR), a water utility, on Friday declared a quarterly dividend of USD0.165 per share of the company's stock.
WTR: 26.51 (-0.15)

Aqua America Declares December 2014 Dividend
Business Wire - Fri Oct 03, 10:41AM CDT
The Board of Directors of Aqua America, Inc. (NYSE: WTR) declared a quarterly cash dividend payment of $0.165 per share payable on December 1, 2014, to all shareholders of record on November 14, 2014.
WTR: 26.51 (-0.15)

Aqua America Growth Strategy Results in New Water and Wastewater Acquisitions in Texas
Business Wire - Wed Oct 01, 2:20PM CDT
Aqua America, Inc. (NYSE: WTR) announced today that its Texas subsidiary, Aqua Texas, has acquired the water and wastewater system assets of Texas H2O, a family-owned utility based in Mansfield, Texas, for $2.8 million. The acquisition totals nine systems that provide water service to approximately 3,300 people in Hood, Tarrant, Johnson and Parker counties. Two of the nine systems also provide wastewater service to about 600 people.
WTR: 26.51 (-0.15)

Aqua America Subsidiary Acquires Virginia Water Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 6:20PM CDT
The Virginia subsidiary of Aqua America Inc. (WTR) acquired Lake Caroline, the water system assets of Caroline Water Company, for $1.1 million.
WTR: 26.51 (-0.15), CWCO: 12.22 (-0.28), AWK: 52.69 (+0.33), CTWS: 36.22 (-0.68)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading